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algorithm is more reflective of the estimated prevalence of IBS subgroups
in the general population.
Conclusions: Our study was the first attempt to develop a classification
algorithm based on distinct GI symptoms experienced by patients with
differing types of IBS. Further research needs to be undertaken to validate
this symptom-based algorithm against objective measures.
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RELATIONSHIP BETWEEN LENGTH OF HOSPITAL STAY,
PATIENT SEVERITY, TRANSFUSIONS AND ENDOSCOPY
TREATMENT IN BLEEDING PEPTIC ULCER: REPORT FROM
THE MULTICENTRE RING STUDY GROUP
Omero Triossi, M.D., Marco Soncini, M.D., Pietro Leo, M.D.*,
Carlo Buniolo, RING Study Group. H. S. Maria delle Croci, Ravenna,
Italy; H. S. Carlo Borromeo, Milano, Italy; H. S. Orsola Malpighi,
Bologna, Italy and QUBIsoft, Padova, Italy.
Purpose: The RING project has actively filed two years of hospital
discharge modules (HDM) from over 50 gastroenterology units in Italy.
The large amount of data collected permits to explore the clinical man-
agement of serious gastroenterologic diseases: this work focuses on bleed-
ing peptic ulcers (BPU).
Methods: Among the 23,863 HDMs progressively collected from RING
centers, 822 (3.4%) main diagnoses of BPU were reported. Age, number of
concomitant diseases, number of procedures and transfusions were consid-
ered as factors revealing the patient clinical severity. RING centers were
stratified according to monthly frequency of BPU cases: group A 
4/month; group B  4/month. A multivariate ANOVA model for each
strata was then used in order to assess significant association with length of
hospital stay (LHS).
Results: Similar means in length of stay were found between the two centre
strata group: 7.1 days (247 cases) and 7.4 days (575 cases) for group A and
group B, respectively. Number of concomitant diagnoses and number of
procedures resulted significantly associated with LHS in both strata groups.
Group A showed an additional significant relationship with LHS, with
reverse correlation, due to the presence of transfusions. In this group,
patients with transfusions reported a mean value of LHS of 5.3 days, much
lower than 8.4 days for the remaining patients. On the contrary, age of the
patient and EGDS were found not to influence LHS.
Conclusions: RING data seem to confirm that LHS is mainly influenced by
patient clinical severity, in term of number of concomitant diseases and
procedures, rather than by the age of the patient. On the other side,
trials-proved EGDS efficacy in reducing rebleeding incidence seems not to
reflect in significant LHS shortening. Further data (HB serum level e.g.) are
needed to interpret lower LHS for patient with transfusions, at least in
centers with higher prevalence of BPU.
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A COST-UTILITY ANALYSIS OF SECONDARY PROPHYLAXIS
FOR VARICEAL HEMORRHAGE
Joel H. Rubenstein, M.D., Glenn M. Eisen, M.D., M.P.H.,
John M. Inadomi, M.D.*. University of Michigan Health System, Ann
Arbor, MI and Vanderbilt University Medical Center, Nashville, TN.
Purpose: Secondary prophylaxis for esophageal variceal hemorrhage (VH)
is recommended, but there has never been a cost-utility analysis of its
implementation. We aimed to compare the cost-utility of various strategies
for the secondary prophylaxis of VH including 1) observation alone (OBS),
2) medical therapy (MED), 3) endoscopic band ligation (EBL), 4) endo-
scopic band ligation plus medical therapy (EBLM), and 5) transjugular
intrahepatic portosystemic shunt (TIPS), and to examine the effect of
adherence on these strategies.
Design: A Markov process model was developed for all five strategies, and
includes surveillance, risk of hepatic encephalopathy, complications, and
non-adherence. Data sources: Published literature and the Health Care
Financing Administration. Target population: People with cirrhosis and a
history of controlled VH. Time horizon: Three years. Perspective: Third
party payer. Outcome measure: Incremental cost-effectiveness ratios for
quality-adjusted-life years (QALYs) gained.
Results: Base-case analysis: Combination EBLM was the optimal strat-
egy, dominating all other strategies including OBS, meaning that it was
more effective and less expensive than the others. In addition, EBL alone
dominated OBS and TIPS in terms of QALYs, and MED alone dominated
the strategy of OBS in terms of QALYs. Sensitivity analysis: Important
variables affecting the optimal strategy were the odds ratio of VH with EBL
compared to MED, the odds ratio of VH with EBLM compared to EBL,
and patients’ preferences regarding taking the medication as reflected in the
associated toll exacted on the health state utility. Variations in these
parameters within the range of clinical plausibility allowed EBL or MED
to become the optimal strategy. TIPS was the optimal strategy only if
adherence rates for all strategies were less than 12%. Monte Carlo analysis:
Neither OBS nor TIPS was ever the optimal strategy, and EBLM was
optimal in 61% of cases. If the variables identified in the sensitivity analysis
were controlled, then EBLM was optimal in 95% of cases.
Conclusions: TIPS should be reserved only for patients with very poor
adherence. Otherwise, patients are best served by medications, endoscopic
band ligation, or a combination of both, depending on the comparative rates
of rebleeding with each, and patients’ preferences regarding medical ther-
apy. The redundancy of combination band ligation plus medical therapy
can improve outcomes, particularly in the setting of poor patient adherence.
666
ARE MEDICATIONS THAT AFFECT PLATELET FUNCTION
ASSOCIATED WITH BLEEDING FOLLOWING THERAPEUTIC
ENDOSCOPY? A CASE-CONTROL STUDY
Nadeem Hussain, M.D., Alan N. Barkun, M.D.*,
Youssef Toubouti, M.Sc., Elham Rahme, Ph.D.,
Boivin Jean-Francois, M.D. McGill University, Montreal, QC, Canada.
Purpose: To determine whether the intake of anti-platelet agents is asso-
ciated with a significant risk of post-procedural hemorrhage. Few data exist
on the relative safety of performing therapeutic endoscopy in patients on
anti-platelet agents.
Methods: A case-control study was performed where cases unequivocally
bled (ascertained using previously published criteria) as a result of an
endoscopic polypectomy (P) of the upper or lower gastrointestinal tract, an
endoscopic sphincterotomy (ES), or a percutaneous endoscopic gastros-
tomy (PEG) occurring in a tertiary care centre with experienced endosco-
pists. Two or 3 controls (patients in whom no bleeding occurred) were
selected randomly for each case by consulting an administrative institu-
tional database. Matching was done by sex, age  10 years, time of
procedure  2 years, and procedure-type in patients with available clinical
data. Conditional logistic regression modeling was used to assess the
association between exposure to anti-platelet medication (within the prior
10 days) and post-procedural bleeding while adjusting for possible con-
founders. The study was powered to confidently rule out a clinically
significant association.
Results: Amongst the 42 cases, 48% bled during the procedure, while 40%
bled in the first 14 days thereafter, and 12% bled later yet. 48% required
blood transfusions (mean: 3.4 units). The 54 controls and 42 cases were
well matched for age (68.416 vs 68.617 yrs), sex (53% vs 52% female),
PTT (normal values in 90% vs 81%), and platelet count (over 60,000x109/L
in 99% vs 100%). Differences were noted, amongst the ES group, in the
prevalence of pre-procedural cholangitis (20% vs 45%), and an abnormal
INR (over 1.5 in 1% vs 12%). Overall, 20% of controls and 21% of cases
had been exposed to an anti-platelet agent. After adjusting for possible
effects attributable to an elevated PTT, INR and the presence of cholangitis
(for the ES patients), exposure to an anti-platelet agent in all patients was
not associated with post-procedural bleeding (risk ratio  1.13, 95% CI:
0.44-2.88).
Conclusions: This case-control trial provides one of very few available
controlled data to support the belief that exposure to anti-platelet agents
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